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1 In this context "total" is used to describe that amount of each of the three estrogens obtained after acid hy-(drolysis and ether extraction of plasma and urine samples, as will be apparent from the analytical method used (10) . In the subsequent description and discussion the word "total" is usually omitted for brevity.
The results were compared with simultaneous studies of endogenous creatinine excretion. The effect of the tubular blocking agent probenecid on plasma concentration, urinary excretion, and renal clearance of each of these hormones was also determined. Methods Clinical material. Primiparous or multiparous women, ages 17 to 40 years, in the last 6 weeks of normal pregnancy were selected from the wards and clinics of Grady Memorial Hospital. There was no evidence of hypertension or of cardiac or renal disease. One patient, however, was found to have symptomless carcinoma of the breast at delivery. There were no stillbirths and no multiple births in this series.
Renal clearance studies. Subjects were studied both as outpatients and in the wards. The outpatients were studied 3 to 4 hours after breakfast, and those in the wards 3 to 4 hours after breakfast or 2 to 3 hours after a liquid lunch. All subjects were given sufficient water orally to establish a diuresis of 3 to 15 ml per minute and adequate water thereafter to maintain a diuresis during the study period. Outpatients were studied in the sitting position, and urine was collected by voiding. Subjects in the wards were studied in the semirecumbent position in bed, and urine was again collected by voiding. In three subjects an indwelling soft rubber catheter was used, the bladder being irrigated with normal saline at the end of each collection period. This procedure, however, was subsequently abandoned, since it was found that adequate collections were obtained by voiding. Urine collection periods were 20 to 90 minutes. These comparatively long periods were necessary to obtain adequate amounts of urinary estrone, estradiol-17fi and estriol for analysis. The clearance values given in Figure 3 usually represent the mean of two or three clearance periods. Owing to the necessary length of the clearance period, it was impossible to obtain more than one clearance period in a proportion of subjects. Blood samples were drawn in heparinized syringes at the middle of each collection period. Renal clearance figures were calculated by standard methods (12) from the plasma and urine estrogen concentrations. Plasma and urine endogenous creatinine was measured by the method of Brod and Sirota (13) substituted for the acidic filtrate, the plasma dilution being 1: 7. This modification was shown by Haugen (14) to give marginally higher plasma creatinine concentrations (mean + 3%). This method measures "creatinine chromogen," and not "true" creatinine. Probenecid studies. After control clearance studies had been made, probenecid (Benemid), 2.5 g, was given orally, and water intake maintained. One hour after the administration of probenecid, the bladder was emptied, and urine was discarded. Clearance studies were then repeated as in the control period.
Estrogen analysis. Plasma was separated from erythrocytes within an hour after withdrawal of the blood samples. Both plasma and urine samples were usually stored at -15°C until analyzed, but in some cases the urine samples were acidified (10) and stored at room temperature. The total plasma and urine concentrations of estrone, estradiol-17fi, and estriol were estimated by the method of Preedy and Aitken (10 Tables I to III . In Figure 4 the relationship of the renal clearance of estriol to the plasma estriol concentration was expressed by the regression line constructed from the regression equation for the cubic term, y = 362.614 -18.891x + 0.087x2 + 0.008x', where y = renal clearance of estriol in milliliters per minute, and x = the plasma estriol concentration in micrograms per 100 ml. The relationship between the two variables was further analyzed by calculation of the correlation co-efficient, r1,, together with the 95% confidence limits.
Results
The concentrations of estrone, estradiol-17,/ and estriol in random samples of urine and plasma taken from 41 subjects during the last 6 weeks of normal pregnancy are given in Figure 1 . Between 19 and 41 determinations were made in each category. Urine and plasma samples were not necessarily taken from the same patients. The mean urinary concentrations of estrone, estradiol-17,8, and estriol were 11.4, 2.17, and 238 lg per 100 ml, respectively. Corresponding mean concentrations in the plasma specimens were 6.64, 1.00, and 11.7 /g per 100 ml, respectively. The ratio between the mean concentrations (estrone: estradiol-17fi: estriol) was 5.27: 1:110 in urine and 6.64: 1: 11.7 in plasma.
The relationship between the urine to plasma concentration ratios (U/P ratio) of the three estrogens in paired samples is given in Figure 2 . These samples were obtained from 21 subjects.
In nine of these subjects, however, the plasma estradiol-17,8 level was too low for adequate measurement. The U/P ratios for these subjects were consequently omitted. In five of the subjects the average ratio of two or three paired samples was used. The mean U/P ratio for estrone was 2.08 The results of determinations of renal clear-clearance rate was significantly greater than the ance of endogenous estrone and estriol in 22 sub-mean endogenous creatinine clearance rate (p = jects and of estradiol-17,/ in 15 subjects, are given < 0.01). Of the 22 subjects in whom estriol in Figure 3 , together with figures for the simul-clearances were determined, 12 had an estriol taneously determined endogenous creatinine clear-clearance that exceeded the mean creatinine clearance in 17 of the subjects. The mean renal clear-ance by more than twice the standard deviation.
ance rates for estrone, estradiol-17,8, and estriol in Of the 17 subjects in whom simultaneous estriol milliliters per minute (SE in parentheses) were and creatinine clearances were determined, nine 11.95 (1.47), 8.80 (1.07), and 205.5 (24.1), re-had ratios of estriol clearance to creatinine clear- Table I . In all subjects there was a fall in the clearance rate of each of the three estrogens. The mean differences between clearance rates before and after probenecid were these: estrone, -5.1 ml per minute (p = 0.02); estradiol-17,8y -6.6 ml per minute (p = < 0.05); and estriol, -70.5 ml per minute (p = < 0.01). The p figures indicate that the fall was significant in each group. With the mean clearance rate after probenecid expressed as a percentage of the mean control rate, the values obtained were 29, 27, and 29 for estrone, estradiol-17,/, and estriol, respectively.
In Table II the effects of probenecid upon the urinary excretion rates of estrone, estradiol-17/3, and estriol in the same subjects are shown. A diminished excretion of each of the three estrogens occurred in each subject in whom determinations were made. The mean differences between excretion rates before and after probenecid in micrograms per minute were as follows: estrone, -0.28; estradiol-178, -0.068; and estriol, -9.67. These differences were significant (p = < 0.02) for estrone and estriol and of borderline significance for estradiol-17,8 (p = < 0.06).
In Table III the plasma estrogen concentrations before and after probenecid administration are given. Each subject showed an increased plasma concentration of estrone and estriol after probenecid. The mean differences between plasma concentrations before and after probenecid in micrograms per 100 In the case of estrone and estradiol-17,8 no significant relationship could be established between the plasma concentration of the estrogens and their respective clearance rates. However, a relationship appeared to exist in the case of estriol. This is shown in Figure 4 , where plasma estriol concentration in micrograms per 100 ml is plotted against renal estriol clearance in milliliters per minute. The relationship is best defined by the fitted line, calculated as described under Statistical analysis. The correlation coefficient, r,,y, is -0.70, and r2X, is 0.49. The 95% confidence limits are -0.38 and -0.87, indicating the significance of the correlation. Discussion The results reported in this study have to be interpreted with particular regard to the limitations of the methods of analysis. The methods employed measure separately the total amounts of estrone, estradiol-17/3, and estriol present in plasma and urine. They provide no information about the various physicochemical forms in which these hormones may exist, such as the nature and extent of conjugation with glucuronic, sulfuric, or other acids, and no information regarding the degree of binding to the plasma proteins of either free (i.e., unconjugated) or conjugated steroid.
Furthermore, it is unlikely that the three estrogens exist in the same physicochemical forms in both urine and plasma. It is also probable that the various moieties contributing to a total estrogen as measured in this study will have different renal clearance rates. Binding to plasma proteins may alter the availability of free or conjugated steroids for renal excretion. All these factors may clearly affect any deductions based on or involving a comparison between plasma and urine estrogen concentrations. Consequently U/P ratios and renal clearance rates of estrone, estradiol-17/,, and estriol should be regarded not necessarily as values for single substances, but as composite values for the various U/P ratios and clearance rates of the moieties composing total estrone, estradiol-17fi, and estriol respectively.
The data given in Figure 1 permit a comparison of estrogen concentration ratios in urine with those in plasma in late pregnancy, from the analysis of a large number of random samples. Whereas the mean concentration ratio of estrone to estradiol-17,8 is similar both in urine and plasma, the mean concentration ratio of estriol to either estrone or estradiol-17,8 is markedly different, the ratios being approximately 10 times higher in urine than in plasma, confirming the impression previously referred to (11) .
A comparison of estrogen U/P ratios by using paired samples (Figure 2) showed that the mean U/P ratios of estrone and of estradiol-17/3 do not differ significantly, but that the mean U/P ratio of estriol was approximately 20 times greater than the mean U/P ratio of either estrone or estradiol-17,B, a statistically significant difference.
It was to be expected that the renal clearance values for the three estrogens would preserve this general relationship. This is confirmed by finding that the mean clearance rates for estrone, estradiol-17,8, and estriol were 11.95, 8.80, and 205 ml per minute, respectively, the latter clearance rate being significantly different from the other two rates.
The values in Figure 3 indicate a wider scatter of the estriol clearance rates compared with those of estrone and estradiol-17,8. This is, however, merely a function of the larger values of the estriol clearance, since the coefficients of variation in each group were similar (estrone, 58; estradiol-17,/, 56; and estriol, 55).
Simultaneous inulin and estrogen clearances could not be estimated in our subjects, since the presence of inulin interfered with the determination of urinary estrogens by greatly reducing recovery. This could not be overcome by dilution of the urine, as in the case of glucose (17) .
A comprehensive study by Sims and Krantz (18) has shown that in the last 4 to 6 weeks of pregnancy the mean endogenous creatinine: inulin clearance ratio is 0.97, SD 0.15, so that it might be assumed that the creatinine clearances obtained in the present study would give a good indication of the glomerular filtration rates in our subjects.
Sims and Krantz (18) , however, measured the clearance of "true" creatinine, which has been shown (19, 20) to correspond very closely to the inulin clearance, whereas the Brod and Sirota method (13) we used measures the "creatinine chromogen" clearance. Since the latter method gives somewhat higher plasma "creatinine" levels, creatinine clearance values lower than the simultaneously determined inulin clearance would be expected. In fact, however, Brod and Sirota (13) found a mean "creatinine chromogen": inulin clearance ratio of 1.00 in a series of normal subjects. Our own experience, using substantially the same methods, has yielded ratios somewhat greater than unity in a small number of normal subjects. No significant difference was found between the inulin clearance figures in the last 6 weeks of pregnancy reported by Sims and Krantz (18) and the creatinine clearances in the present study. However, Doolan, Alpen, and Theil (19) found that in the normal subject the mean "true" creatinine: inulin clearance ratio was 1.03, whereas with the Brod and Sirota method (13), the ratio was 0.86.
Although our creatinine clearance values probably provide a good estimate of the glomerular filtration rate, they may possibly underestimate the glomerular filtration rate by approximately 15% (19) . Even if this were so, it will be observed from Figure 3 , and from the values given in the results section, that the relationship between the creatinine clearance and the clearance of each of the three estrogens would not be substantially affected. Figure 3 shows (6) .
In the human, the glucosiduronates of steroid hormones and their metabolites appear in general to have higher renal clearance rates than the nonconjugated steroids, particularly in the plasma 17-hydroxycorticoids (5, 6 ). In the above mentioned studies, however, the renal clearance of glucosiduronate steroids rarely exceeded the en-dogenous creatinine clearance, whereas in our series the clearance rate of estriol exceeded the mlean creatinine clearance by a significant amllount in approximately half the subjects.
There is a good evidence for the renal tubular secretion of nonsteroidal glucosiduronates, such as salicylacyl and salicylphenyl glucosiduronates in the human (22) and of various phenol glucosiduronates, but not the free phenols, in the chicken and goat (23) .
Because of this evidence, and since the majority of urinary estriol in late pregnancy is in the glucosiduronate form (24) , it appears likely that the moiety of total plasma estriol which contributes chiefly to the high estriol clearance rates reported here is a glucosiduronate of estriol.
Summary
The renal clearance of endogenous estrogens in late pregnancy has been studied in subjects in late pregnancy. Concentrations of endogenous estrone, estradiol-17,8, and estriol in the plasma and urine samples used in the studies were determined after acid hydrolysis and ether extraction.
The urine: plasma concentration ratios (U/P ratios) and renal clearance values for estrone and estradiol-17/3 differed markedly from those for estriol. The mean U/P ratios for estrone and estradiol-17,8 were 2.08 and 1.47, respectively, and the mean U/P ratio for estriol was 37.4. The mean renal clearances for estrone and estradiol-17,/ were 11.95 and 8.80 ml per minute, respectively, and the mean renal clearance of estriol was 205.5 ml per minute, a value significantly higher than the simultaneously determined mean endogenous creatinine clearance of 131.3 ml per minute. This indicates that estriol is secreted in part at least by the renal tubule, probably as a glucosiduronate.
Probenecid administration reduced the urinary excretion rate and renal clearance of all three estrogens, at the same time raising the plasma estrogen concentration. This suggests that in spite of initial low clearance values, both estrone and estradiol-17ft also are partly excreted by the renal tubule.
Some evidence for the existence of a tubular maximal secretion rate (Tm) for estriol was found.
